prikaz prve stranice dokumenta Kortikosteroidi i šećerna bolest: nove spoznaje i perspektive u liječenju
  Download
PDF 674.99 KB
Scientific paper - Review paper
Kortikosteroidi i šećerna bolest: nove spoznaje i perspektive u liječenju
Medicina Fluminensis : Medicina Fluminensis, 52 (2016), 2; 185-189. urn:nbn:hr:184:714529
Jurišić Eržen, Dubravka; Benko, Koraljka; Starčević-Klasan, Gordana; Jerković, Romana

Cite this document

Jurišić Eržen, D., Benko, K., Starčević Klasan, G. & Jerković, R. (2016). Kortikosteroidi i šećerna bolest: nove spoznaje i perspektive u liječenju. Medicina Fluminensis : Medicina Fluminensis, 52. (2), 185-189. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:714529

Jurišić Eržen, Dubravka, et al. "Kortikosteroidi i šećerna bolest: nove spoznaje i perspektive u liječenju." Medicina Fluminensis : Medicina Fluminensis, vol. 52, no. 2, 2016, pp. 185-189. https://urn.nsk.hr/urn:nbn:hr:184:714529

Jurišić Eržen, Dubravka, Koraljka Benko, Gordana Starčević Klasan and Romana Jerković. "Kortikosteroidi i šećerna bolest: nove spoznaje i perspektive u liječenju." Medicina Fluminensis : Medicina Fluminensis 52, no. 2 (2016): 185-189. https://urn.nsk.hr/urn:nbn:hr:184:714529

Jurišić Eržen, D., et al. (2016) 'Kortikosteroidi i šećerna bolest: nove spoznaje i perspektive u liječenju', Medicina Fluminensis : Medicina Fluminensis, 52(2), pp. 185-189. Available at: https://urn.nsk.hr/urn:nbn:hr:184:714529 (Accessed 21 November 2024)

Jurišić Eržen D, Benko K, Starčević Klasan G, Jerković R. Kortikosteroidi i šećerna bolest: nove spoznaje i perspektive u liječenju. Medicina Fluminensis : Medicina Fluminensis [Internet]. 2016 June 01 [cited 2024 November 21];52(2):185-189. Available at: https://urn.nsk.hr/urn:nbn:hr:184:714529

D. Jurišić Eržen, K. Benko, G. Starčević Klasan and R. Jerković, "Kortikosteroidi i šećerna bolest: nove spoznaje i perspektive u liječenju", Medicina Fluminensis : Medicina Fluminensis, vol. 52, no. 2, pp. 185-189, June 2016. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:714529. [Accessed: 21 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (croatian)Kortikosteroidi i šećerna bolest: nove spoznaje i perspektive u liječenju
Title (english)Corticosteroids-induced diabetes mellitus: modern concepts and perspectives in the treatment
AuthorDubravka Jurišić Eržen
AuthorKoraljka Benko
AuthorGordana Starčević-Klasan
AuthorRomana Jerković
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (croatian)
Kortikosteroidi izazivaju pojavu steroidnog oblika šećerne bolesti mnogobrojnim mehanizmima. Kortikosteroidi povećavaju otpornost na inzulin u stanicama jetre i stanicama drugih tkiva kao što su masno i mišićno tkivo. Imaju štetno djelovanje na beta-stanice gušterače, smanjenja unosa glukoze u stanice i indukcije apoptoze. Čimbenici rizika za razvoj steroidne šećerne bolesti su doza i dugotrajnost primjene kortikosteroida, dob, obiteljska anamneza šećerne bolesti, debljina, rasa i prethodno postojanje šećerne bolesti. Pristup pacijentima sa steroidnom šećernom bolešću je dijeta, tjelovježba i samokontrola glukoze u plazmi. Ako glikemija natašte ili nakon obroka naraste preko 11,1 mmol/l preporučena je primjena inzulina.
Abstract (english)
The mechanism of corticosteroids-induced diabetes mellitus is multifactorial. Corticosteroids induce hepatic and extrahepatic insulin resistance. Corticosteroids have direct harmful effects on insulin-secreting beta cells of the pancreas, decreasing in glucose transport into the beta cells and inducing apoptosis. The risk of corticosteroids-induced diabetes increases with the corticosteroids dosage, duration of therapy, age, family history of diabetes mellitus, obesity, ethnicity and high blood glucose concentrations before corticosteroids therapy. Treatment of patients with corticosteroids-induced hyperglycaemia is diet, exercise and self-monitoring of blood glucose level. Patients with persistent fasting and daytime blood glucose concentrations over 11.1 mmol/L, the treatment with insulin is recommended.
Keywords (croatian)
Keywords (english)
Languagecroatian
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleMedicina Fluminensis : Medicina Fluminensis
Numberingvol. 52, no. 2, pp. 185-189
p-ISSN0025-7729
URN:NBNurn:nbn:hr:184:714529
Publication2016-06-01
Document URLhttp://hrcak.srce.hr/158502
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2017-04-21 08:46:41